drugset / Trial / NCT06482359
Lot Consistency Study of COVID-19 and Influenza Combination Vaccine
RandomizedCrossoverSingle-blindPrevention
Summary
The goal of Phase 3 Study is Comparing the Safety and Immune Response of Three Batches of a COVID-19 and Flu Combination Vaccine in Seniors Aged 65+
Timeline
- Start
- 2025-02-01
- Primary completion
- 2025-11-16
- Completion
- 2026-05-17
Outcome
Outcome not reported
Stopped: “It was decided to not move forward with the study.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fluzone HD trivalent | Unknown | 0.5 ml | Intramuscular |
| Comparator | coformulated CIC Vaccine | Vaccine | 0.5 ml | Intramuscular |